We work with a wide range of clients from the life sciences sector including:
- pharmaceutical companies
- biotechnology companies
- medical device and diagnostic companies
- manufacturers, distributors and logistics companies
- banks and financial institutions.
We work with companies of all sizes, from start-ups to multinational industry leaders. Whether it's a complex matter affecting your entire business or a more routine matter, we have the knowledge and commitment to assist you.
We have particular expertise in:
"extremely sharp and pragmatic"
The Legal 500 UK 2015
- acquisitions and disposals
- investments and financings
- licensing deals
- collaboration agreements
- manufacturing, distribution and logistics contracts
- multi-jurisdictional disputes
- intellectual property
- tax structuring
- competition/anti-trust issues
- employment, pensions and incentives advice
- data privacy issues
- real estate for laboratory and manufacturing facilities, including associated planning and environmental matters.
Woodford Investment Management
We advised on the set up and launch of Woodford Patient Capital Trust plc, an innovative investment trust offering exposure to early-stage companies with outstanding intellectual property and long-term return opportunities.
We have advised this AIM-listed development stage pharmaceutical company on a number of out-licensing and collaboration deals, including the out-licensing of the worldwide rights to its proprietary adenosine receptor antagonist technology to a US company.
We have advised GSK on a number of trade mark matters including a multi-jurisdictional dispute relating to the colour of its global blockbuster inhaler product, Seretide.
We have advised BTG plc, a FTSE-250 international specialist pharmaceutical company, on a range of M&A, financing and licensing matters including its $220 million acquisition of EKOS Corporation, an International vascular business, headquartered in Seattle, US.
We have assisted this specialist oncology company, headquartered in Cambridge (Massachusetts), with commercial, competition, data protection and employment advice related to its entry into the European market.
We have advised this global biopharma company on a variety of significant and more routine commercial contracts and a dispute with a licensing partner.
We have advised this Mumbai-listed company on a wide variety of matters, including the sale of its domestic formulations division to Abbot Healthcare for $3.8 billion.
Lansen Pharmaceutical Holdings Limited
We advised Lansen on its acquisition from Novartis AG of the rights to sell Sicorten Plus, a dermatological product, in China.
Eisai Europe Ltd
We have advised this Japanese headquartered pharmaceutical company on confidential employment and HR matters in the UK for many years.
We have advised this Global 500 company on corporate governance, data protection, competition law compliance, and medical advertising in Asia.